For evaluation of genotype effect on the risk of hypertension, four SNPs were chosen: two SNPs (AGT and ACE) related to renin-angiotensin-aldosterone system and other two SNPs (ADM and CACNB2) newly identified in genome-wide association studies. Here, CACNB2 is linked to hypertensive disorder.